Abstract
The chromosomal region 10q23-24 is frequently deleted in a number of tumour types, including prostate adenocarcinoma and glioma. A candidate tumour-suppressor gene at 10q23.3, designated PTENor MMAC1, with putative actin-binding and tyrosine phosphatase domains has recently been described. Mutations in PTEN have been identified in cell lines derived from gliomas, melanomas and prostate tumours and from a number of tumour specimens derived from glial, breast, endometrial and kidney tissue. Germline mutations in PTEN appear to be responsible for Cowden disease. We identified five PTEN mutations in 37 primary prostatic tumours analysed and found that 70% of tumours showed loss or alteration of at least one PTEN allele, supporting the evidence for PTEN involvement in prostate tumour progression. We raised antisera to a peptide from PTEN and showed that reactivity occurs in numerous small cytoplasmic organelles and that the protein is commonly expressed in a variety of cell types. Northern blot analysis revealed multiple RNA species; some arise as a result of alternative polyadenylation sites, but others may be due to alternative splicing.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gray, I., Stewart, L., Phillips, S. et al. Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN. Br J Cancer 78, 1296–1300 (1998). https://doi.org/10.1038/bjc.1998.674
Issue Date:
DOI: https://doi.org/10.1038/bjc.1998.674
This article is cited by
-
Intermittent fasting uncovers and rescues cognitive phenotypes in PTEN neuronal haploinsufficient mice
Scientific Reports (2018)
-
Dual inhibition of survivin and MAOA synergistically impairs growth of PTEN-negative prostate cancer
British Journal of Cancer (2015)
-
PTEN stabilizes TOP2A and regulates the DNA decatenation
Scientific Reports (2015)
-
Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K–AKT pathway
Clinical and Translational Oncology (2015)
-
Prostate cancer ETS rearrangements switch a cell migration gene expression program from RAS/ERK to PI3K/AKT regulation
Molecular Cancer (2014)